Graybar Ascend review

It depends on how much weight you put on carrier strength. Judged purely on structure and current crediting terms, this is a competitive accumulation FIA — no fees, a strong cap, high participation rates, and clean withdrawal and death benefit provisions. Judged as a 10-year commitment, it's a product from a mid-tier carrier (A.M. Best B++, S&P not rated), which is a meaningfully longer runway to be exposed to a single insurer's claims-paying strength than most buyers realize when they focus only on the rate.

The rational buyer here wants index-linked growth with a guaranteed floor and doesn't want to pay a rider fee for an income guarantee they may never use. The 9.25% cap and the 150% participation rate on the S&P MARC 5% strategy are both genuinely strong numbers for a fee-free FIA, and the absence of any Mortality & Expense charge, product fee, or administration charge means every dollar of interest credited actually reaches the accumulation value. For someone who has already decided they want a decade-long FIA and is comfortable with the carrier, this is a clean way to get it.

This product is best suited to someone in their 50s or early 60s with qualified or non-qualified retirement dollars they genuinely don't need for 10 years, who wants growth potential above a plain fixed annuity but doesn't want to shop or pay for an income rider. It's a poor fit for anyone who prioritizes carrier financial strength above all else, anyone who might need income guarantees down the road, and anyone in California, Idaho, Maine, Minnesota, New York, Michigan, or North Carolina, where the product isn't offered.

You're not buying stock market exposure. You're buying an insurance contract that credits interest based on how selected indices perform, subject to a cap on one strategy and participation-rate limits on the other two, with your principal protected from index losses by the contract's floor. The Fixed Account option (5.00% current declared rate, with a 0.50% guaranteed minimum floor per the consumer brochure) is a straightforward alternative if you'd rather skip index-linked crediting altogether. None of the three crediting strategies here involve a spread, and there's no premium bonus inflating the entry number — this is priced as a straight accumulation product, not a marketing product.

Graybar Ascend offers three crediting methods across three indices, all on an annual point-to-point basis. The S&P 500 strategy can be credited under a 9.25% cap (100% participation) or, on a separate uncapped track, 55% participation with no cap. The S&P 500 Dynamic Intraday TCA Index strategy runs at 80% participation, uncapped, with a 20% guaranteed floor if current rates are ever reduced. The S&P MARC 5% Index (a volatility-controlled index Wink labels the "S&P 500 Multi-Asset Risk Control 5% Index") pays 150% participation, uncapped, with a 25% guaranteed floor. Only the capped S&P 500 strategy has an upper limit on credited interest — the other two trade a lower guaranteed floor for the chance at uncapped upside, which is a real strategy decision the buyer has to make at allocation time, not something the contract decides for you.

The absence of any base contract fee is the second most important thing about this product, because it's unusual. Ceres Life discloses no Mortality & Expense charge, no product fee, no administration charge, and no annual contract fee on Graybar Ascend. That matters because fee-free accumulation FIAs are not the norm — many competitors either charge an explicit annual fee or build the cost into a lower cap. Combined with included Nursing Home and Terminal Illness surrender-charge waivers at no extra cost, this product's cost structure is genuinely clean; the price you pay is carrier strength and commitment length, not ongoing charges.

You're trading 10 years of full liquidity for that index-linked growth potential. Up to 10% of the Accumulation Value can be withdrawn penalty-free each contract year starting after the first anniversary, and RMDs from qualified accounts can be drawn without triggering a surrender charge or MVA starting in year one — a genuinely useful feature for IRA money. Anything above the 10% free amount during the surrender period is subject to both the declining surrender charge schedule below and a Market Value Adjustment, which can move the withdrawal penalty up or down depending on where interest rates have moved since issue. Terminal Illness and Nursing Home Waivers of Surrender Charge are built in at no cost, which softens — but doesn't eliminate — the liquidity risk of a full decade lock-up.

There's no rider fee to weigh here because there's no rider — this base version of Graybar Ascend has neither a premium bonus nor an income rider of any kind. That's worth being explicit about, because Ceres Life sells two other products off the same platform: Graybar Ascend with Bonus, which pays a 14% account-value premium bonus but funds it with a lower 3.50% current fixed account rate and a 10-year annual vesting schedule (0% vested in year one, climbing to fully vested only in year 11), and Graybar IncomePlus, which carries a built-in GLWB income rider. If you want the bonus or the guaranteed income, those are different products with different tradeoffs — this base version's advantage is a meaningfully stronger 5.00% fixed account rate and no vesting cliff to navigate, in exchange for skipping the upfront bonus. The real tradeoff on this version is structural, not fee-based: caps and participation rates limit upside compared to direct market exposure, and the Minimum Guaranteed Cash Surrender Value of 87.5% of premium (accruing at 0.15%-3%) sets the floor if you surrender early, not full principal.

Legal Entity: Ceres Life Insurance Company

Parent: Salem Group Holdings

A.M. Best Rating: B++